Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: JanyBlueEyes who wrote (582)	12/11/1997 12:03:00 PM
From: R. M. Rosenthal	Read Replies (2) \| Respond to of 5736

Janybird: Nothing like getting slapped awake by Skip first thing in the AM! I have indeed tried to do my DD and read virtually all of the cites and references. I was however, momentarily thrown when I rechecked the very first reference on the Research Page re CCSI Product and Market (Research Magazine 10/97) and read: "Bilirubin affects more than half of all the babies born and nearly 100 percent of all premature children. Every infant born is monitored for it." As this appears to be a somewhat less than entirely accurate statement, I respectfully submit that this may not be the very best cite with which to lead off the research, especially for newcomers. Thanks again to you and my honorabe abuser for your ongoing efforts to help us all stay as informed and knowledgable as possible. RMR